CN110804046B - Zinc ion proportional photoacoustic probe with mitochondrial targeting function and application thereof - Google Patents
Zinc ion proportional photoacoustic probe with mitochondrial targeting function and application thereof Download PDFInfo
- Publication number
- CN110804046B CN110804046B CN201810881189.8A CN201810881189A CN110804046B CN 110804046 B CN110804046 B CN 110804046B CN 201810881189 A CN201810881189 A CN 201810881189A CN 110804046 B CN110804046 B CN 110804046B
- Authority
- CN
- China
- Prior art keywords
- probe
- photoacoustic
- imaging
- xanthene
- photoacoustic imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 48
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 230000002438 mitochondrial effect Effects 0.000 title claims abstract description 12
- 230000008685 targeting Effects 0.000 title abstract description 7
- 238000003384 imaging method Methods 0.000 claims abstract description 51
- 238000001727 in vivo Methods 0.000 claims abstract description 8
- 238000000338 in vitro Methods 0.000 claims abstract description 7
- 125000001834 xanthenyl group Chemical class C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 229940125904 compound 1 Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 229940125782 compound 2 Drugs 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 150000001450 anions Chemical class 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 229940126214 compound 3 Drugs 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 238000006000 Knoevenagel condensation reaction Methods 0.000 claims description 2
- 239000000090 biomarker Substances 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000006210 cyclodehydration reaction Methods 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 10
- 230000005284 excitation Effects 0.000 abstract description 6
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000012984 biological imaging Methods 0.000 abstract description 2
- 239000012472 biological sample Substances 0.000 abstract description 2
- 230000035515 penetration Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000011701 zinc Substances 0.000 description 74
- 239000000243 solution Substances 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 21
- 238000010521 absorption reaction Methods 0.000 description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 238000001514 detection method Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 8
- 210000003141 lower extremity Anatomy 0.000 description 8
- 210000003470 mitochondria Anatomy 0.000 description 8
- RUVJFMSQTCEAAB-UHFFFAOYSA-M 2-[3-[5,6-dichloro-1,3-bis[[4-(chloromethyl)phenyl]methyl]benzimidazol-2-ylidene]prop-1-enyl]-3-methyl-1,3-benzoxazol-3-ium;chloride Chemical compound [Cl-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C(N(C1=CC(Cl)=C(Cl)C=C11)CC=2C=CC(CCl)=CC=2)N1CC1=CC=C(CCl)C=C1 RUVJFMSQTCEAAB-UHFFFAOYSA-M 0.000 description 7
- 150000003732 xanthenes Chemical class 0.000 description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000007995 HEPES buffer Substances 0.000 description 6
- 238000010186 staining Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- IUNJCFABHJZSKB-UHFFFAOYSA-N 2,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C(O)=C1 IUNJCFABHJZSKB-UHFFFAOYSA-N 0.000 description 4
- -1 Cl- Chemical class 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000000295 emission spectrum Methods 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 238000012634 optical imaging Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 231100000263 cytotoxicity test Toxicity 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000006197 hydroboration reaction Methods 0.000 description 3
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 238000005935 nucleophilic addition reaction Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 238000010226 confocal imaging Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000004896 high resolution mass spectrometry Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- AEYWPRODWLOEFK-UHFFFAOYSA-N n-methylmethanamine;pyridine Chemical compound CNC.C1=CC=NC=C1 AEYWPRODWLOEFK-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical group [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- JYYNAJVZFGKDEQ-UHFFFAOYSA-N 2,4-dimethyl pyridine Natural products CC1=CC=NC(C)=C1 JYYNAJVZFGKDEQ-UHFFFAOYSA-N 0.000 description 1
- XQVKLMRIZCRVPO-UHFFFAOYSA-N 4-[(2-arsonophenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C12=CC=C(S(O)(=O)=O)C=C2C=C(S(O)(=O)=O)C(O)=C1N=NC1=CC=CC=C1[As](O)(O)=O XQVKLMRIZCRVPO-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 101100491335 Caenorhabditis elegans mat-2 gene Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 101100382568 Danio rerio caspa gene Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000834948 Homo sapiens Tomoregulin-2 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000010750 Metalloproteins Human genes 0.000 description 1
- 108010063312 Metalloproteins Proteins 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CVRXLMUYFMERMJ-UHFFFAOYSA-N N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine Chemical compound C=1C=CC=NC=1CN(CC=1N=CC=CC=1)CCN(CC=1N=CC=CC=1)CC1=CC=CC=N1 CVRXLMUYFMERMJ-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 238000012879 PET imaging Methods 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000020221 Short stature Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000679125 Thoron Species 0.000 description 1
- 102100026160 Tomoregulin-2 Human genes 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229940003871 calcium ion Drugs 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000000033 nuclear magnetic resonance titration Methods 0.000 description 1
- 238000011580 nude mouse model Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 238000000482 two photon fluorescence microscopy Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Acoustics & Sound (AREA)
- Radiology & Medical Imaging (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
The invention discloses a zinc ion proportion photoacoustic probe with a mitochondrial targeting function, which has the following structural formula:
or
The probe can be excited by visible light, has red light emission, can weaken the damage of an excitation light source to a biological sample, and has deeper tissue penetration depth. In vitro and in vivo photoacoustic imaging experiments show that the probe provided by the invention is used for Zn2+Has better photoacoustic imaging performance, can be applied to biological imaging, mitochondrial marking and Zn2+The photoacoustic imaging has a simple chemical mechanism, good biocompatibility and good application prospect.
Description
Technical Field
The invention belongs to the technical field of biosensing. In particular to a xanthene derivative which can be used as Zn with a mitochondrion targeting function2+Proportional photoacoustic probes are used in the fields of cell imaging, mitochondrial marking, and photoacoustic imaging.
Background
In recent years, photoacoustic imaging has become a focus of attention as a new imaging mode. The photoacoustic imaging combines the advantages of optical imaging and ultrasonic imaging, on one hand, the photoacoustic imaging penetrates deeper than pure optical imaging (can break through high-resolution optical imaging depth 'soft' limit (1mm) such as laser confocal microscopy (LCSM), two-photon excitation microscopy (TPEF) and optical weak coherence tomography (OCT)), on the other hand, the photoacoustic imaging has higher resolution than traditional MRI and PET imaging, the image resolution can reach submicron and micron order, and high-resolution molecular imaging can be realized, on the other hand, due to the narrow line width of laser, the photoacoustic imaging can realize selective excitation of high-specificity spectral tissues by utilizing the high spectral selective absorption difference of biological tissues, not only can reflect the structural characteristics of tissues, but also can realize functional imaging, and a new imaging method and technical means different from the traditional medical imaging technology are created, the advantages of optical imaging and the acoustic imaging are combined, photoacoustic imaging is a background-free and non-invasive imaging technique that is very important for in vivo imaging.
Most of the current reports on Probes for detecting ions in organisms by using a Photoacoustic Imaging mode are used for detecting cell microenvironment or other biological species, such as Jefferson Chan project group, an example of aza-fluoro-borane probe APC-1 is designed to realize proportion Photoacoustic Imaging on Copper ions, but is irreversible due to reactive response and difficult to be used for real-time tracking and monitoring fluctuation of metal ions (see Li Hao, Zhang Pamela, Smaga Lukas P., Hoffman Ryan A., Chan Jefferson, Photoacustic Probes for Ratiometric Imaging of Copper (II), J.Am.chem.Soc. 2015,50, 15628-); one near-infrared proportional photoacoustic probe ER-P was designed in Tangbo project group for detecting cell polarity and realizing imaging of liver tissue of diabetic mice (see Xiao Haibin, Wu Chuanchhen, Li Ping, Gao Wen, Zhang Wen, Zhang Wei, Tong Lili, Tang Bo, Ratiometric photo-acoustic imaging of end plastic particulate in injected liquid tissues of diabetes, chem. Sci.,2017,10, 7025-; gil G. Westmeyer topic group synthesized an example of a Calcium-ion Photoacoustic Imaging probe CaSPA based on the partial cyanine structure design and achieved dynamic monitoring of Calcium ions in heart organs and zebra fish brains (see Roberts Sheryl, Seeger Markus, Jiang Yuanyuun, Mishra Angrag, Sigmuld Felix, Stelzl Anja, Lauri Antonella, Symvulidis Panagitis, Rolbeski Hannes, Preller Mathias, De n-Ben X. Lu ions, Razansky Daniel, Orschmann Tanja, Desboures Sabrina C., tscher Vea Paul, Bacth Thoron, Ntzeristoris Valis, Westmeyer G., Seecor G, Seoac J, phosphor J.2718, Checker J.2718, Souchi Osaka J.2718).
Intracellular metal ions play a vital role in cells and provide an important environment for the normal operation of cells. And zinc ion (Zn)2+) The second most abundant transition metal ions in the human body are mainly distributed in nerve cells (Zn in brain tissue)2+The content of the active component reaches 0.1-0.5 mM). Zn2+Is an indispensable element for normal physiological development and metabolism of human bodies. About 90% Zn in living body2+Tightly combined with metalloproteins and various enzymes, playing an important role in physiological function regulation and cell construction, Zn2+Transport protein and metallothionein strictly control Zn in vivo2+Dynamic balancing of (2). A great deal of research shows that Zn in the life body2+The deficiency of (b) will lead to a series of diseases: zn2+Promoting the growth and the tissue regeneration of organisms and Zn in the bodies of male teenagers2+The absence will result in short stature and incomplete development of sex characteristics; furthermore Zn2+The zinc has important physiological effects on brain development and functions, zinc participates in the process of transmitting signals to a central nervous system, memory and thinking skills are increased, and the brain development and maturation lag is caused by zinc deficiency. Zn2+Metabolic disorders play a major role in the development and progression of many neurodegenerative diseases such as Alzheimer's Disease (AD), and the like. Zn2+Are associated with many diseases, but Zn is involved in2+The roles played by these physiological processes are not fully understood, and thus the understanding of Zn in the body of a living body is well understood2+The dynamic process and spatial-temporal distribution of (2) appear to be very urgent.
Disclosure of Invention
The invention discloses a Zn used for Zn for the first time2+A probe for proportional photoacoustic imaging. The pyridine dimethylamine is connected to a xanthene fluorophore through nucleophilic addition with aldehyde group and then through hydroboration reduction, and forms a four-coordination structure with ortho-hydroxyl to identify Zn2+Meanwhile, the probe contains positive charges and can target mitochondria. By confocal imaging, the mitochondrial targeting ability of the probe can be determined.
The specific technical scheme of the invention is as follows:
a xanthene derivative has the following structural formula:
said xanthene derivatives being characterised by being capable of binding anions, such as Cl-、Br-，I-，NO3 -Or PF4 -。
Another object of the present invention is to provide the xanthene derivatives of the present invention in Zn2+Application in photoacoustic imaging. Further, the xanthene derivative is proportional Zn2+Photoacoustic probe, useful for in vitro or in vivo Zn2+Proportional photoacoustic imaging can also be used for marking mitochondria of living cells.
The xanthene derivative can be applied to the fields of cell imaging, biomarkers, photoacoustic imaging and sensing.
The invention connects the pyridine dimethylamine with xanthene fluorophore through nucleophilic addition with aldehyde group and then through hydroboration reduction, and forms a four-coordination structure with ortho-position hydroxyl group to identify zinc ion, and meanwhile, the probe contains positive charge and can target mitochondria. By confocal imaging, the mitochondrial targeting ability of the probe can be determined. Explanation of probe pair Zn by in vitro and in vivo photoacoustic imaging experiments2+Has better photoacoustic imaging performance.
The synthetic route of the xanthene fluorescent probe is as follows:
specifically, after adding sodium triacetoxyborohydride to 2, 4-dihydroxybenzaldehyde and dimethylpyridine amine, carrying out nucleophilic addition with aldehyde groups, carrying out a secondary hydroboration reduction reaction to obtain a compound 1, and carrying out a retro-Knoevenagel reaction, a ring formation dehydration reaction on the compound 1 and a compound 2 or 3 to obtain the xanthene derivative.
Has the advantages that: the photoacoustic probe provided by the invention can be used for detecting Zn2+The small-molecule photoacoustic imaging probe is simple in preparation method.
Zn of the invention2+The photoacoustic probe is capable of being excited by visible light and has red light emission, thereby attenuating damage to the biological sample from the excitation light source and having a deep tissue penetration depth.
In vitro and in vivo photoacoustic imaging experiment tableThe probe pair of the invention is Zn2+Has better photoacoustic imaging performance, can be applied to biological imaging, mitochondrial marking and Zn2+The photoacoustic imaging has a simple chemical mechanism, good biocompatibility and good application prospect.
Drawings
FIG. 1 shows an emission spectrum of HD-Zn.
FIG. 2 shows an absorption spectrum of HD-Zn.
FIG. 3.HD-Zn2+Ultraviolet absorption intensity ratio at concentration (A)680/A750) Fitted curve with concentration.
Figure 4. variation of the ratio of the absorption intensity of HD-Zn for different metal ions.
Figure 5. variation of the ratio of HD-Zn absorption intensity for different pH.
FIG. 6.HD-Zn chelated Zn2+Is detected.
Figure 7 in vitro photoacoustic imaging experimental results of HD-Zn.
FIG. 8 shows the result of cytotoxicity test of HD-Zn.
Figure 9 shows the results of experiments on HD-Zn targeting to live cell mitochondria.
FIG. 10 shows in vivo photoacoustic imaging experimental results for HD-Zn.
FIG. 11 addition of 1eq Zn to HD-Zn2+ESI-MS graph of (A).
FIG. 12 shows different equivalent of Zn added to HD-Zn2+Nuclear magnetic titration of (c).
Detailed Description
The following is a detailed description of the embodiments of the present invention, which is implemented on the premise of the technical solution of the present invention, and detailed implementation manners and specific operation procedures are given, but the scope of the present invention is not limited to the following examples.
Example 1: preparation of Compound 1
2, 4-dihydroxybenzaldehyde (10mmol), dimethylpyridine amine (10mmol) and triacetoxyborohydrideSodium chloride (20mmol) was dissolved in 100mL Dichloroethane (DCE), reacted for 24 hours under Ar atmosphere in ice bath, and then 100mL of NaHCO was added3The reaction was quenched, extracted 3 times with 50mL portions of dichloromethane, the organic phase collected, Na2SO4Drying, spin-drying the solvent to obtain a yellow solid, performing column chromatography, and performing methanol: dichloromethane (CH)2Cl2) After the crude product is obtained by 50:1(v/v), CH is added2Cl2And methanol, the final white product compound 1, yield: 31 percent.1H NMR(400 MHz,DMSO-d6)δ10.38(s,1H),9.13(s,1H),8.51(ddd,J＝4.9,1.8,0.9Hz,2H),7.85–7.70(m, 2H),7.42(dt,J＝7.9,1.1Hz,2H),7.26(ddd,J＝7.6,4.8,1.1Hz,2H),6.94(d,J＝8.1Hz,1H), 6.21(d,J＝2.4Hz,1H),6.19-6.14(m,J＝8.1Hz,1H),3.75(s,4H),3.57(s,2H).13C NMR(101 MHz,DMSO-d6)δ159.00,158.27,158.21,149.17,137.28,131.23,123.15,122.70,114.42,106.30, 103.31,58.72,54.53,40.68,40.62,40.47,40.42,40.21,40.00,39.79,39.58,39.37。
Example 2: preparation of photoacoustic probe HD-Zn
In a dry round-bottom flask, compound 1(1mmol), K was added2CO3(1mmol) and anhydrous DMF (3ml) and the mixture was stirred at room temperature for 30min under nitrogen blanket and then starting compound 2(0.5 mmol dissolved in 5ml anhydrous DMF) was injected with syringe. Heating the reaction mixture to 70 deg.C under nitrogen protection for 3 hr, evaporating solvent under reduced pressure, and purifying the residue by silica gel column Chromatography (CH)2Cl2Methanol 50:1, v/v) gave the desired product HD-Zn in a bluish-green color with a yield of 52.6%.1H NMR(400MHz,Methanol-d4)δ8.61(d,J＝14.7Hz,1H),8.40(d, J＝4.8Hz,2H),7.67(td,J＝7.7,1.7Hz,2H),7.55(d,J＝7.3Hz,1H),7.48–7.28(m,7H),7.19 (dd,J＝7.4,5.0Hz,2H),6.78(s,1H),6.34(d,J＝14.7Hz,1H),4.20(t,J＝7.3Hz,2H),3.80(d,J ＝18.7Hz,6H),2.72-2.55(m,2H),1.83(t,J＝7.1Hz,4H),1.71(s,6H),0.98(t,J＝7.3Hz, 3H).13C NMR(101MHz,Methanol-d4)δ177.05,162.35,162.20,157.86,154.53,148.02,145.08, 141.82,141.77,137.48,137.42,134.82,129.55,128.74,126.59,126.18,123.24,122.57,122.37, 11453,114.25,112.24,102.49,102.42,58.38,55.08,50.34,48.25,48.11,48.04,47.90,47.82, 47.68,47.61,47.40,47.19,46.97,46.01,28.59,27.10,23.74,20.77,20.33,10.25 High Resolution Mass Spectrometry (HRMS): Calc.623.3381, found.623.3378.
Example 3: emission Spectrum test of HD-Zn
The concentration of the spectroscopic test used in the present invention was 5. mu.M, and the test solvent was HEPES solution (50mM,100 mM KNO) mixed with 1% DMSO3pH7.4), and the excitation wavelength is 633nm when the emission spectrum is measured. Zn2+The solution being ZnCl2Dissolving in water.
The emission spectrum of HD-Zn is shown in FIG. 1. When 1 equivalent of Zn is added2+Then, the fluorescence is enhanced by about 1/3 times, and the wavelength is blue-shifted; shows that the probe HD-Zn is used for Zn in the fluorescence spectrum2+The response of (a) is not significant.
Example 3: HD-Zn absorption spectrum test and detection limit calculation
The absorption spectrum used in the present invention was measured at a concentration of 5. mu.M in HEPES solution (50mM,50mM KNO) mixed with 1% DMSO as a test solvent3pH7.4) as shown in FIG. 2, when Zn is added2+The absorption at 680nm is gradually increased, the absorption at 750nm is gradually decreased, the ratio of the absorption at 680nm to the absorption at 750nm is plotted against the concentration, as shown in FIG. 3, it can be found that the absorption ratio has a better linear relationship with the concentration, and 1 equivalent of Zn is added2+The rear absorption ratio is enhanced by about 10 times. The wavelength of the current commercial photoacoustic detector is required to be between 680nm and 950nm, and the molar absorption coefficient is required to be large, and the molar absorption coefficient of the probe is 3.62 multiplied by 10 calculated by Labert's law A ∈ bc4L·mol-1·cm-1And the molar absorption coefficient increased to 5.88X 10 after adding 1 equivalent4L·mol-1·cm-1Therefore, the absorption wavelength of the probe meets the requirement of a commercial photoacoustic instrument and can be used for photoacoustic imaging. The detection limit can be calculated according to the formula 3s/slope, where s represents the background noise during detection and slope represents the slope of the titration curve, and the formula defines the concentration corresponding to a signal that exceeds background noise by a factor of 3 as the detection limit. According to 0-5. mu.M Zn2+Data on UV titration at concentrationThe slope of the line can be determined by linear fitting (FIG. 3), and the detection limit of the probe is calculated to be about 24.2nM, which indicates that the probe has a lower detection limit and high sensitivity.
Example 3: selectivity test for HD-Zn
To 3mL of HEPES buffer solution (50mM, pH 7.40, containing 1% DMSO, v/v) of a fluorescent probe (5. mu.M), 100. mu.M Na was added, respectively+、K+、Mg2+、Ca2+、10μM Fe2+、Fe3+、Cu2+、Cu+、Ba2+、Hg2+、Cr3+、Ni2+、Cd2+And Zn2+And (5) carrying out absorption spectrum test after uniformly mixing.
As can be seen from FIG. 4, the addition of other cations to the probe solution caused little change in the ratio of the absorption intensities of the solution when 10. mu.M Zn was added2+Ratio of absorption intensity of rear solution (A)680/A750) The change is obvious, and the enhancement is about 10 times. These experimental results show that the probe HD-Zn is coupled with Zn2+Has good selectivity and Zn resistance2+The proportional metering response capability is not disturbed by other cations.
Example 4: influence of pH on the Probe HD-Zn
1 equivalent of Zn was added to 3mL of the probe solution (5. mu.M) and the probe solution (5. mu.M)2+Adding a certain volume of HCl aqueous solution or NaOH aqueous solution into the HEPES solution, adjusting the solution to different pH values, and performing fluorescence spectrum test after the solution is stable.
As shown in FIG. 5, the ratio of the absorption intensity of the probe HD-Zn at physiological pH 4.5-8 remained substantially constant. The experiment shows that the probe has small change of the absorption intensity ratio in the physiological pH range and is suitable for Zn in a life system2+And (4) detecting and imaging.
Example 4: reversibility test of HD-Zn
The chelate fluorescent probe has the advantages that the reversible detection of metal ions can be realized, and the embodiment detects Zn for the probe HD-Zn2+Was investigated for reversibility. According to previous studies, when 5. mu.M Zn was added to a 5. mu.M probe solution2+Then, A680/A750It will be enhanced. As can be seen from FIG. 6, Zn was added to the resulting solution by means of chelate competition2+Chelating agent TPEN (5. mu.M), all of which can convert Zn2+Deprivation of blood, A680/A750Returning to near original level, adding 5 μ M Zn2+Then, A680/A750The probe can be enhanced and repeated for three times, and the probe has better reversibility. The experimental result proves that HD-Zn can be applied to Zn2+Reversible ratiometric assays were performed.
Example 5: in vitro photoacoustic imaging experiment of HD-Zn
Considering the high molar extinction coefficient of HD-Zn probe and the absorption spectrum for Zn2+According to the absorption spectrum, 680nm and 750nm lasers are selected to be used in HEPES buffer solution (50mM,100 mM KNO) of 5 MuM HD-Zn3Ph7.4, 2% DMSO) for photoacoustic signal acquisition. It was found that the probe solution had a strong photoacoustic signal at 750nm laser, while the signal was weak at 680 nm. With Zn2+The increase of the concentration of the photoacoustic signal PA680 begins to increase, the photoacoustic signal PA750 begins to decrease, and the variation trend of the photoacoustic signal is more consistent with the absorption spectrum result (FIG. 7).
Example 6: cytotoxicity assay of HD-Zn
The cells adopted by the invention are all human breast cancer cells (MCF-7 cells). The digested cells were seeded in 96-well plates at a density of 10 per well4One/well at 37 ℃ 5% CO2The culture was continued for 24 hours. After the removal of stale culture medium, cells were cultured for 12 hours in cell culture medium with different concentrations of HD-Zn (1, 5, 10, 20. mu.M). The culture was terminated by adding 10. mu.L of MTT (5mg/mL) per well and continuing the culture for 4 hours. The culture medium was aspirated, 150. mu.L of DMSO was added to each well, and OD570 was measured using a microplate reader after shaking for 10 minutes on a shaker.
MTT cytotoxicity test results are shown in FIG. 8, and when the concentration of the complex is 0-20 mu M, the cell survival rate after 12-hour culture is more than 80%, which proves that the probe has low cytotoxicity and can be used for cell imaging.
Example 7: experiment for co-staining experiment of HD-Zn and commercial mitochondrial dye Mito-Tracker Green on living cell mitochondria
The digested MCF-7 cells were seeded in petri dishes at 37 ℃ with 5% CO2The culture was continued for 24 hours under the conditions of (1) to allow adhesion. After washing the cells with PBS solution and incubating the cells with HD-Zn (5. mu.M) cell culture for 10 minutes, the cells were incubated with Mito-Tracker Green (500nM) cell culture for 30 minutes, washed three times with PBS solution and imaged.
FIG. 9 shows the cell co-staining images of HD-Zn and the commercial mitochondrial dye Mito-Tracker Green, (a) the co-staining image collected by the Mito-Tracker Green channel with an excitation wavelength of 488nm and an emission wavelength range of 490-540nm, (b) the co-staining image collected by the HD-Zn channel with an excitation wavelength of 633nm and an emission wavelength range of 640-750nm, and (c) the superimposed images of the images a and b; (d) MCF-7 cell brightfield; (e) graphs (a-c) fluorescence intensity of probes HD-Zn and Mito-Tracker Green on the white line; (f) correlation graph of probe HD-Zn and Mito-Tracker Green fluorescence intensity. The emitting region of mitochondrial dye Mito-Tracker Green and the emitting region of HD-Zn are overlapped, the contact ratio of the emitting region and the emitting region of HD-Zn is found to be high, and the co-staining coefficient can be calculated to be as high as 0.92, so that the HD-Zn disclosed by the invention can target living cell mitochondria and can be used for marking the living cell mitochondria.
Example 8: in vivo photoacoustic imaging experiment of HD-Zn
Photoacoustic experiments of living bodies were performed on nude mice, and photoacoustic signals were collected under two laser light sources of 680nm and 750 nm. Before injecting HD-Zn, the hind limb of the mouse is firstly subjected to photoacoustic imaging, and the photoacoustic signal of the subcutaneous part of the hind limb of the mouse is found to be very weak. Then 50. mu.L of 20. mu.M HD-Zn HEPES buffer (50mM,100 mM KNO) was injected into the left and right hind limbs, respectively3Ph7.4, 2% DMSO) signal acquisition, it was found that the mouse subcutaneous injection region had a strong photoacoustic signal PA680 at 680nm, while the photoacoustic signal PA750 at 750nm of the same region was weak, which is consistent with photoacoustic imaging in solution (fig. 10 a). The ratio PA680/PA750 of the photoacoustic signals of the left and right hind limbs is 1.85 and 2.36 respectively. Thereafter, 100. mu.L of ZnCl was injected into the right limb of the mouse2Aqueous solution (1mM) to the left of mouseThe hind limb was injected with the same volume of saline and signal acquisition was performed after 10 minutes. Both PA680 and PA750 signals were found to be reduced in the left hind limb, probably because the signal of the probe HD-Zn solution was weakened as a result of dilution of the subcutaneous solution or diffusion under the skin. It is noted that when the ratio of the signals measured in the area is plotted, it can be found that the ratio PA680/PA750 of the left hind limb is 2.07, the value is slightly increased compared with the value before injection, and the ratio PA680/PA750 of the photoacoustic signals of the right hind limb is 3.54 (FIG. 10b), and the experimental result shows that the HD-Zn can realize subcutaneous Zn2+The photoacoustic detection of (2). Compared with the intensity-variable photoacoustic imaging probe, the proportional metering photoacoustic imaging probe has the characteristic that the detection is not influenced by the probe concentration. HD-Zn thus achieves subcutaneous Zn in mice2+The ratio of (a) to (b) measures photoacoustic imaging detection.
Example 9: HD-Zn combined with Zn2+Mechanism of (2)
The invention combines HD-Zn and Zn2+The coordination of zinc ions with 3N and ortho-O of the pyridyldimethylamino is presumed in response to the absorption spectrum data and the mass spectrum data, and a mass spectrum peak with m/z of 343.33 appears in the mass spectrum (figure 11) and is assigned as [ HD-Zn + Zn ] & lt & gt]2+The molecular weight of (2) can also be found by NMR titration (FIG. 12) along with Zn2+The concentration is increased, and the proton of the pyridine dimethylamino group is shifted, thereby indicating Zn2+The coordination to N and the shift of the proton on the xanthene ring indicate that the O conjugated to it is also coordinated. Thus, with Zn2+The coordination structure is as shown in FIG. 11.
Claims (10)
1. A xanthene derivative is characterized by having the following structural formula:
2. Xanthene derivatives according to claim 1, which can be combined with anions.
3. Xanthene derivatives according to claim 2, characterized in that the anion is selected from the group consisting of Cl-、Br-，I-，NO3 -Or PF4 -。
4. Use of a xanthene derivative according to any of claims 1-3 in Zn2+Application in photoacoustic imaging.
5. Use according to claim 4, characterized in that the xanthene derivative is a ratiometric Zn2+A photoacoustic probe.
6. Use according to claim 4, characterized in that said xanthene derivatives are useful in vitro or in vivo Zn2+And (4) proportional photoacoustic imaging.
7. Use according to claim 4, characterized in that the xanthene derivatives are used for mitochondrial marking of living cells.
8. The use according to claim 4, wherein the xanthene derivatives are used in cellular imaging, biomarkers, photoacoustic imaging and sensing.
9. A process for the preparation of a xanthene derivative according to any of claims 1 to 3, wherein the xanthene derivative according to the invention is obtained by subjecting compound 1 and compound 2 or 3 to a retro-Knoevenagel reaction and subsequent cyclodehydration, according to the following reaction scheme:
10. the process according to claim 9, wherein the compounds 1, K are2CO3Reacting with anhydrous DMF at room temperature under the protection of nitrogen, adding a compound 2 or 3, heating to 50-90 ℃ under the protection of nitrogen for reaction, and evaporating the solvent under reduced pressure to obtain the xanthene derivative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810881189.8A CN110804046B (en) | 2018-08-04 | 2018-08-04 | Zinc ion proportional photoacoustic probe with mitochondrial targeting function and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810881189.8A CN110804046B (en) | 2018-08-04 | 2018-08-04 | Zinc ion proportional photoacoustic probe with mitochondrial targeting function and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110804046A CN110804046A (en) | 2020-02-18 |
| CN110804046B true CN110804046B (en) | 2022-03-25 |
Family
ID=69486912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810881189.8A Active CN110804046B (en) | 2018-08-04 | 2018-08-04 | Zinc ion proportional photoacoustic probe with mitochondrial targeting function and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110804046B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102971303A (en) * | 2010-05-31 | 2013-03-13 | 科学及工业研究委员会 | Zn (Il) based colorimetric sensor and process for the preparation thereof |
| CN105693650A (en) * | 2016-04-01 | 2016-06-22 | 中国农业科学院农产品加工研究所 | Zinc-ion fluorescent probe compound, and preparation method and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9211349B2 (en) * | 2012-06-05 | 2015-12-15 | Molecular Targeting Technologies, Inc. | Molecular probes for multimodality imaging of anionic membrane surfaces |
-
2018
- 2018-08-04 CN CN201810881189.8A patent/CN110804046B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102971303A (en) * | 2010-05-31 | 2013-03-13 | 科学及工业研究委员会 | Zn (Il) based colorimetric sensor and process for the preparation thereof |
| CN105693650A (en) * | 2016-04-01 | 2016-06-22 | 中国农业科学院农产品加工研究所 | Zinc-ion fluorescent probe compound, and preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| A nobel near-infrared fluorescent probe for sensitive detection of β-galactosidase in living cells;Jingtuo Zhang et al.;《Analytica Chimica Acta》;20170308(第968期);第97-104页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110804046A (en) | 2020-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111303102A (en) | Nitroreductase responsive hypoxic probe compound and preparation and application thereof | |
| CN112694431B (en) | Nitroreductase in hypersensitive fluorescent probe detection bacteria and application in bacterial infection | |
| CN112142721B (en) | Near-infrared two-region thiopyran salt fluorescent compound capable of targeting mitochondria and preparation method and application thereof | |
| CN113072574B (en) | Fluoroborazine 29897 | |
| CN110862819B (en) | PH fluorescent probe based on near-infrared fluorescent dye and preparation method and application thereof | |
| CN113956265B (en) | Near-infrared molecular probe based on malondialdehyde response, preparation method and application thereof | |
| CN112745303A (en) | Hypoxic fluorescent probe and application thereof | |
| Ni et al. | Convenient construction of fluorescent markers for lipid droplets with 1, 8-naphthalimide unit | |
| Zhao et al. | A salicylaldehyde benzoyl hydrazone based near-infrared probe for copper (ii) and its bioimaging applications | |
| CN114195774B (en) | Photosensitizer with hypochlorous acid activated fluorescence and mitochondrial targeting functions and preparation method and application thereof | |
| CN112047979A (en) | Fluorescent probe Mito-HNO, preparation method thereof and application thereof in detection of HNO in mitochondria | |
| CN111592482A (en) | PH reversible activation type photo-thermal/photodynamic/fluorescent integrated probe molecule | |
| CN111410652B (en) | Preparation of mitochondrion targeting type near-infrared fluorescent probe with aggregation-induced emission effect | |
| Zhang et al. | Tuning long-term mitochondrial imaging and photodynamic therapy capabilities through rational design of aggregation-induced emission luminogens | |
| CN112624960B (en) | NTR-1 response type fluorescent probe based on benzindole, preparation method and application | |
| Tang et al. | A new metal-free near-infrared fluorescent probe based on nitrofuran for the detection and bioimaging of carbon monoxide releasing molecule-2 in vivo | |
| CN110407873B (en) | Tumor microenvironment H2O2Response crosslinking near-infrared molecular probe and application thereof | |
| CN110804046B (en) | Zinc ion proportional photoacoustic probe with mitochondrial targeting function and application thereof | |
| CN116217515B (en) | Methylene blue probe, preparation method thereof and application thereof in detection of cysteine | |
| CN114106027B (en) | Fluoroboron fluorescent dye-tetrazine fluorescent probe and preparation method and application thereof | |
| CN110092792B (en) | Iron ion probe of rhodamine B lactam Schiff base based on FRET mechanism | |
| CN113651828B (en) | Near-infrared fluorescent probe for detecting chromium ions and aluminum ions as well as preparation method and application of near-infrared fluorescent probe | |
| CN110183482B (en) | Near-infrared fluorescent probe for monitoring pH of lysosome and preparation method and application thereof | |
| CN109678888B (en) | Oxazine compound and application thereof | |
| CN107312043A (en) | A kind of fluorescence probe for recognizing heavy metal copper ion and its synthesis and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |